Created at 3:20 p.m. Jan, 23, 2025
Author: jambags90
Related Note: 1577803381607 1
Rationale for change

I just had a question on UWorld (Id 19834) that states Candidal skin injections are used to confirm intact T-lymphocyte function, and should be used to test for T-cell dysfunction rather than B-cell dysfunction. The question asked to identify the appropriate testing for X-linked agammaglobulinemia (flow cytometry), but Candidal injection was an answer choice. This card states it is used to confirm B-cell defects like X-linked agammaglobulinemia, but Uworld seems to contradict this.

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
Changed Tags
!AK_UpdateTags::AnKing_Image::!Subjects::Immunology_&_Pathology::Immunodeficiency_syndromes
#AK_Step1_v12::#Bootcamp::Immunology::10_Immunodeficiency_Syndromes::02_B-cell_and_T-cell_Variants #AK_Step1_v12::!FLAG_THESE_CARDS::SketchyPathAdds #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Immunology_+_General_Pathology::Immunology #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Physeo::08_Immunology::02_Immunodeficiencies::01_Bruton_Agammaglobulinemia #AK_Step1_v12::^Systems::Immunology::JBadds #AK_Step1_v12::^Other::^EXPN::JBadd #AK_Step1_v12::#FirstAid::02_Immunology::03_Immune_Responses::16_Immunodeficiencies::01_B-cell_disorders::*Bruton_Agammaglobulinemia #AK_Step1_v12::#UWorld::Step::544 #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Immunology_&_Pathology::Immunodeficiency_syndromes #AK_Step1_v12::#SketchyPath::11_Immunology::02_Immunodeficiency::01_B-Cell_Disorders_&_DiGeorge_Syndrome #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::Immunodef_syndromes #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Pathoma::02_Inflammation::03_Primary_Immunodeficiency #AK_Step1_v12::#OME::Clinical::Pediatrics::Pediatric_Subspecialties::Immunodeficiencies